TRP beats Q1 earnings estimates, boosts dividend and posts strong segment growth, even as revenues miss expectations and outlook stays intact.
Actualités
Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.
FLOC's $200M Valiant deal adds ESPs to its lift lineup, expanding Permian reach and enabling end-to-end support as wells mature.
CLB's Q1 earnings meet estimates but fall Y/Y as a revenue miss and Middle East disruptions weigh on both key segments.
CVX distributes $6 billion to its shareholders, including $2.5 billion in buybacks and $3.5 billion in dividends during the first quarter
NOV Q1 earnings miss estimates as Middle East disruptions hit operations, while revenues edge past expectations despite a year-over-year decline.
Core Laboratories (NYSE:CLB) executives said first-quarter 2026 results were significantly affected by geopolitical and weather-related disruptions, with the escalation of military conflict in the Middle East creating meaningful project delays, halting some hydrocarbon production, and disrupting mar